Cite
A Novel Target of p53, TCF21, Can Respond to Hypoxia by MAPK Pathway Inactivation in Uterine Corpus Endometrial Carcinoma.
MLA
Li, Qin, et al. “A Novel Target of P53, TCF21, Can Respond to Hypoxia by MAPK Pathway Inactivation in Uterine Corpus Endometrial Carcinoma.” DNA & Cell Biology, vol. 37, no. 5, May 2018, pp. 473–80. EBSCOhost, https://doi.org/10.1089/dna.2017.4062.
APA
Li, Q., Lei, Y., & Du, W. (2018). A Novel Target of p53, TCF21, Can Respond to Hypoxia by MAPK Pathway Inactivation in Uterine Corpus Endometrial Carcinoma. DNA & Cell Biology, 37(5), 473–480. https://doi.org/10.1089/dna.2017.4062
Chicago
Li, Qin, Yong Lei, and Wei Du. 2018. “A Novel Target of P53, TCF21, Can Respond to Hypoxia by MAPK Pathway Inactivation in Uterine Corpus Endometrial Carcinoma.” DNA & Cell Biology 37 (5): 473–80. doi:10.1089/dna.2017.4062.